Hemoglobin A1c levels and aortic arterial stiffness: The cardiometabolic risk in Chinese (CRC) study

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Liang, Jun ^a,b   Zhou, Na ^a   Teng, Fei ^a   Zou, Caiyan ^a   Xue, Ying ^a   Yang, Manqing ^a   Song, Huaidong ^d   Qi, Lu ^b,c  

^a XUZHOU CENTRAL HOSPITAL   (China)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c CHANNING LABORATORY   (United States)

^d SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C;

ADULT; AGE DISTRIBUTION; AGED; ARTERIAL STIFFNESS; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOMETABOLIC RISK; CARDIOVASCULAR RISK; CAROTID TO FEMORAL PULSE WAVE VELOCITY; CHINA; CHINESE; COMMUNITY LIVING; CONCENTRATION RESPONSE; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH SURVEY; HEMOGLOBIN BLOOD LEVEL; HUMAN; MALE; ORAL GLUCOSE TOLERANCE TEST; POPULATION RESEARCH; PULSE WAVE; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE; TREND STUDY;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHINA; FASTING; FEMALE; GLUCOSE TOLERANCE TEST; HEART RATE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; PULSE WAVE ANALYSIS; RISK FACTORS; VASCULAR STIFFNESS;

EID: 84864561200     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038485     Document Type: Article

References (31)

1. Szczepanska-Sadowska E, Cudnoch-Jedrzejewska A, Ufnal M, Zera T, ((2010)) Brain and cardiovascular diseases: common neurogenic background of cardiovascular, metabolic and inflammatory diseases. J Physiol Pharmacol 61:: 509-521.
2. Gillett MJ, ((2009)) International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 32:: 1327-1334.
3. Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, et al. ((2006)) Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 27:: 2588-2605.
4. Sutton-Tyrrell K, Najjar SS, Boudreau RM, Venkitachalam L, Kupelian V, et al. ((2005)) Elevated aortic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in well-functioning older adults. Circulation 111:: 3384-3390.
5. Blacher J, Asmar R, Djane S, London GM, Safar ME, ((1999)) Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension 33:: 1111-1117.
6. Chae CU, Pfeffer MA, Glynn RJ, Mitchell GF, Taylor JO, et al. ((1999)) Increased pulse pressure and risk of heart failure in the elderly. Jama 281:: 634-639.
7. Cruickshank K, Riste L, Anderson SG, Wright JS, Dunn G, et al. ((2002)) Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function? Circulation 106:: 2085-2090.
8. Chen Y, Huang Y, Li X, Xu M, Bi Y, et al. ((2009)) Association of arterial stiffness with HbA1c in 1,000 type 2 diabetic patients with or without hypertension. Endocrine 36:: 262-267.
9. Matsumae T, Abe Y, Murakami G, Ueda K, Saito T, ((2008)) Effects of glucose metabolism on aortic pulse wave velocity in hemodialysis patients with and without diabetes. Hypertens Res 31:: 1365-1372.
10. Cameron JD, Cruickshank JK, ((2007)) Glucose, insulin, diabetes and mechanisms of arterial dysfunction. Clin Exp Pharmacol Physiol 34:: 677-682.
11. Duprez DA, Cohn JN, ((2007)) Arterial stiffness as a risk factor for coronary atherosclerosis. Curr Atheroscler Rep 9:: 139-144.
12. American Diabetes Association, ((2010)) Diagnosis and classification of diabetes mellitus. Diabetes Care 33 Suppl 1: S62-69.
13. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus ((1997)) Diabetes Care. 20:: 1183-1197.
14. McEniery CM, Yasmin, Hall IR, Qasem A, Wilkinson IB, et al. ((2005)) Normal vascular aging: differential effects on wave reflection and aortic pulse wave velocity: the Anglo-Cardiff Collaborative Trial (ACCT). J Am Coll Cardiol 46:: 1753-1760.
15. Cecelja M, Chowienczyk P, ((2009)) Dissociation of aortic pulse wave velocity with risk factors for cardiovascular disease other than hypertension: a systematic review. Hypertension 54:: 1328-1336.
16. Wildman RP, Farhat GN, Patel AS, Mackey RH, Brockwell S, et al. ((2005)) Weight change is associated with change in arterial stiffness among healthy young adults. Hypertension 45:: 187-192.
17. Wang Y, Wang QJ, ((2004)) The prevalence of prehypertension and hypertension among US adults according to the new joint national committee guidelines: new challenges of the old problem. Arch Intern Med 164:: 2126-2134.
18. Mitchell GF, Hwang SJ, Vasan RS, Larson MG, Pencina MJ, et al. ((2010)) Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation 121:: 505-511.
19. Meaume S, Benetos A, Henry OF, Rudnichi A, Safar ME, ((2001)) Aortic pulse wave velocity predicts cardiovascular mortality in subjects >70 years of age. Arterioscler Thromb Vasc Biol 21:: 2046-2050.
20. Wilkinson IB, Prasad K, Hall IR, Thomas A, MacCallum H, et al. ((2002)) Increased central pulse pressure and augmentation index in subjects with hypercholesterolemia. J Am Coll Cardiol 39:: 1005-1011.
21. Benetos A, Waeber B, Izzo J, Mitchell G, Resnick L, et al. ((2002)) Influence of age, risk factors, and cardiovascular and renal disease on arterial stiffness: clinical applications. Am J Hypertens 15:: 1101-1108.
22. Selvin E, Steffes MW, Zhu H, Matsushita K, Wagenknecht L, et al. ((2010)) Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med 362:: 800-811.
23. Park S, Barrett-Connor E, Wingard DL, Shan J, Edelstein S, ((1996)) GHb is a better predictor of cardiovascular disease than fasting or postchallenge plasma glucose in women without diabetes. The Rancho Bernardo Study. Diabetes Care 19:: 450-456.
24. Shirwany NA, Zou MH, ((2010)) Arterial stiffness: a brief review. Acta Pharmacol Sin. 31(10):: 1267-1276.
25. Winlove CP, Parker KH, Avery NC, Bailey AJ, ((1996)) Interactions of elastin and aorta with sugars in vitro and their effects on biochemical and physical properties. Diabetologia 39:: 1131-1139.
26. Wendt T, Bucciarelli L, Qu W, Lu Y, Yan SF, et al. ((2002)) Receptor for advanced glycation endproducts (RAGE) and vascular inflammation: insights into the pathogenesis of macrovascular complications in diabetes. Curr Atheroscler Rep 4:: 228-237.
27. Davies MJ, Raymond NT, Day JL, Hales CN, Burden AC, ((2000)) Impaired glucose tolerance and fasting hyperglycaemia have different characteristics. Diabet Med17:: 433-440.
28. Mostafa SA, Davies MJ, Srinivasan BT, Carey ME, Webb D, et al. ((2010)) Should glycated haemoglobin (HbA1c) be used to detect people with type 2 diabetes mellitus and impaired glucose regulation? Postgrad Med J 86:: 656-662.
29. Tomiyama H, Hashimoto H, Hirayama Y, Yambe M, Yamada J, et al. ((2006)) Synergistic acceleration of arterial stiffening in the presence of raised blood pressure and raised plasma glucose. Hypertension 47:: 180-188.
30. Wang X, Desai K, Chang T, Wu L, ((2005)) Vascular methylglyoxal metabolism and the development of hypertension. J Hypertens 23:: 1565-1573.
31. Lapolla A, Mosca A, Fedele D, ((2011)) The general use of glycated haemoglobin for the diagnosis of diabetes and other categories of glucose intolerance: still a long way to go. Nutr Metab Cardiovasc Dis 21:: 467-475.